Substance P alone did not affect corneal collagen metabolism, but it significantly amplified TGF-β-induced collagen type I synthesis in human corneal fibroblasts via p38 MAPK signaling through the neurokinin-1 receptor, suggesting a mechanism for neurotrophic keratopathy when corneal nerves are damaged.
SP amplifies TGF-β collagen synthesisSubstance P alone had no effect, but when combined with TGF-β, it significantly increased collagen type I production — a cooperative signaling mechanism dependent on nerve-derived neuropeptide input
What the researchers found
Substance P had no independent effect on corneal fibroblast collagen synthesis or MMP-1 expression. However, it significantly enhanced TGF-β-induced collagen type I synthesis. This effect was mediated by p38 MAPK activation and was blocked by neurokinin-1 receptor inhibition. SP did not affect IL-1β-stimulated MMP-1 expression.
Why it matters
Neurotrophic keratopathy affects people after eye surgery, herpes infections, or diabetes-related nerve damage. Understanding that substance P amplifies wound healing signals provides a molecular explanation for why denervated corneas heal poorly and points toward potential therapeutic strategies using neuropeptide supplementation.
The numbers in context
Substance P enhanced TGF-β-induced collagen synthesis. The cornea is densely innervated with sensory nerve fibers.
How the study worked
In vitro study using cultured human corneal fibroblasts. Collagen type I synthesis measured with and without substance P, TGF-β, and IL-1β. p38 MAPK activation assessed by phosphorylation assays. Pharmacological inhibition of p38 MAPK and neurokinin-1 receptor used to confirm signaling pathway.
Who was studied
Human corneal fibroblast cell cultures
What this study cannot tell us
In vitro study using isolated fibroblasts — doesn't capture the complex corneal wound healing environment with multiple cell types, tear film factors, and immune cells. Only one neuropeptide (substance P) tested. No animal model or clinical validation of the proposed mechanism.
How to read the evidence
Rated preliminary: in vitro mechanistic study using cultured human cells. Provides molecular insight but no clinical or animal model validation.
When this study was published
Published in 2024. Builds on established knowledge of corneal innervation and wound healing.
The bigger picture
This study bridges neuroscience and ophthalmology, showing how nerve-derived neuropeptides directly modulate wound healing at the molecular level. It helps explain the clinical observation that denervated corneas develop progressive thinning and melting, and supports the rationale for nerve growth factor and neuropeptide-based therapies already being explored for neurotrophic keratitis.
Questions still open
- Could topical substance P supplementation improve corneal wound healing in neurotrophic keratopathy patients?
- Do other sensory neuropeptides (CGRP, VIP) also modulate corneal collagen metabolism?
- Is the loss of SP-mediated collagen amplification the primary driver of neurotrophic keratopathy, or are other nerve-derived factors more important?
Common questions
Why do corneal nerve damage patients have trouble healing eye injuries?
Could neuropeptides be used as eye treatments?
Read the original research
Substance P promotes transforming growth factor-β-induced collagen synthesis in human corneal fibroblasts.
American journal of physiology. Cell physiology, 326(5), C1482-C1493
Citation
Sugioka, Koji; Nishida, Teruo; Murakami, Junko; Itahashi, Motoki; Yunoki, Mai; Kusaka, Shunji. (2024). Substance P promotes transforming growth factor-β-induced collagen synthesis in human corneal fibroblasts.. American journal of physiology. Cell physiology, 326(5), C1482-C1493. https://doi.org/10.1152/ajpcell.00084.2024